Analysis of pharmacokinetic profile and ecotoxicological character of cefepime and its photodegradation products.

Cefepime Ecotoxicity testing In silico analysis Photodegradation

Journal

Chemosphere
ISSN: 1879-1298
Titre abrégé: Chemosphere
Pays: England
ID NLM: 0320657

Informations de publication

Date de publication:
28 Feb 2024
Historique:
received: 22 01 2024
revised: 20 02 2024
accepted: 21 02 2024
medline: 2 3 2024
pubmed: 2 3 2024
entrez: 1 3 2024
Statut: aheadofprint

Résumé

An important problem is the impact of photodegradation on product toxicity in biological tests, which may be complex and context-dependent. Previous studies have described the pharmacology of cefepime, but the toxicological effects of its photodegradation products remain largely unknown. Therefore, photodegradation studies were undertaken in conditions similar to those occurring in biological systems in silico, in vitro, in vivo and ecotoxicological experiments. The structures of four cefepime photodegradation products were determined by UPLC-MS/MS method. The calculated in silico ADMET profile indicates that carcinogenic potential is expected for compounds CP-1, cefepime, CP-2 and CP-3. The Cell Line Cytomotovity Predictor 2.0 tool was used to predict the cytotoxic effects of cefepime and related compounds in non-transformed and cancer cell lines. The results indicate that possible actions include: non-small cell lung cancer, breast adenocarcinoma, prostate cancer and papillary renal cell carcinoma. OPERA models were used to predict absorption, distribution, metabolism and excretion (ADME) endpoints, and potential bioactivity of CP-2, cefepime and CP-4. The results obtained in silico show that after 96h of exposure, cefepime, CP-1, CP-2, and CP-3 are moderately toxic in the zebrafish model, while the CP-4 is highly toxic. On the contrary, cefepime is more toxic to T. platyurus (highly toxic) compared to the zebrafish model, similar to products CP-4, CP-3 and CP-2. In vitro cytotoxicity studies were performed by MTT assay, and in vivo acute embryo toxicity studies using Danio rerio embryos and larvae. In vitro showed an increase in the cytotoxicity of products with the longest exposure period i.e. for 8 h. Additionally, at a concentration of 200 μg/mL, statistically significant changes in metabolic activity were observed depending on the irradiation time. In vivo studies conducted with Zebrafish showed that both cefepime and its photodegradation products have only low toxicity. Assessment of potential ecotoxicity included Microbiotests on invertebrates (Thamnotoxkit F and Daphtoxkit F), and luminescence inhibition tests (LumiMara). The observed toxicity of the tested solutions towards both Thamnocephalus platyurus and Daphnia magna indicates that the parent substance (unexposed) has lower toxicity, which increases during irradiation. The acute toxicity (Lumi Mara) of nonirradiated cefepime solution is low for all tested strains (<10%), but mixtures of cefepime and its photoproducts showed growth inhibition against all tested strains (except #6, Photobacterium phoreum). Generally, it can be concluded that after UV-Vis irradiation, the mixture of cefepime phototransformation products shows a significant increase in toxicity.

Identifiants

pubmed: 38428534
pii: S0045-6535(24)00422-3
doi: 10.1016/j.chemosphere.2024.141529
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

141529

Informations de copyright

Copyright © 2024. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Joanna Żandarek (J)

Department of Inorganic and Analytical Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna St, 30-688, Kraków, Poland; Doctoral School of Medical and Health Sciences, Jagiellonian University Medical College, 16 Łazarza St, 31-530, Kraków, Poland.

Paweł Żmudzki (P)

Department of Medicinal Chemistry, Medical College, Jagiellonian University, 9 Medyczna, 30-688 Kraków, Poland.

Darija Obradović (D)

Institute of Physics Belgrade, National Institute of the Republic of Serbia, Pregrevica 118, 11080 Belgrade, Serbia.

Saša Lazović (S)

Institute of Physics Belgrade, National Institute of the Republic of Serbia, Pregrevica 118, 11080 Belgrade, Serbia.

Aleksandar Bogojević (A)

Institute of Physics Belgrade, National Institute of the Republic of Serbia, Pregrevica 118, 11080 Belgrade, Serbia.

Oliwia Koszła (O)

Department of Biopharmacy, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland.

Przemysław Sołek (P)

Department of Biopharmacy, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland.

Monika Maciąg (M)

Department of Biopharmacy, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland; Independent Laboratory of Behavioral Studies, Medical University of Lublin, 4a Chodzki Street, 20 093 Lublin, Poland.

Anita Płazińska (A)

Department of Biopharmacy, Medical University of Lublin, Chodzki 4a, 20-093 Lublin, Poland.

Małgorzata Starek (M)

Department of Inorganic and Analytical Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna St, 30-688, Kraków, Poland.

Monika Dąbrowska (M)

Department of Inorganic and Analytical Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, 9 Medyczna St, 30-688, Kraków, Poland. Electronic address: monika.1.dabrowska@uj.edu.pl.

Classifications MeSH